Autologous CD133+ stem cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD133+ stem cell therapy, covering 2015-12-02 to 2015-12-02. Get the full timeline:
Most recent: Clinical Trial Update: IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting [Phase 2]